PHARMACEUTICALLY ACTIVE ORNITHINE DERIVATIVES, AMMONIUM SALTS THEREOF AND METHODS OF MAKING SAME

In one embodiment, the present invention relates to a new class of ammonium salts of Ndelta-acyl derivatives of Nalpha-(4-amino-4-deoxypteroyl)-L-ornithine compounds having a structure according to formula II-IV. Formula II has the structure of: wherein: R2 represents up to four groups independently...

Full description

Saved in:
Bibliographic Details
Main Authors LIN, MING-TEH, BADER, HENRY, ROSOWSKY, ANDRE, BLUMBERGS, PETER
Format Patent
LanguageEnglish
French
German
Published 29.03.2006
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In one embodiment, the present invention relates to a new class of ammonium salts of Ndelta-acyl derivatives of Nalpha-(4-amino-4-deoxypteroyl)-L-ornithine compounds having a structure according to formula II-IV. Formula II has the structure of: wherein: R2 represents up to four groups independently selected at each occurrence of R2 from the group consisting of hydrogen, C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-8 cycloalkyl, C1-6 alkoxy, chloro, fluoro, hydroxy, and -COOH; R3, R4, and R5 are each independently selected from hydrogen and C1-6 alkyl; or NR3R4 taken combination can form a 5 to 7 member heterocycle having at least one nitrogen ring atom; and x is a real number greater than 0 and less than about 4. The ammonium salts provided by the invention exhibit high inhibitory activity against the growth o methotrexate-resistant cells, and also exhibit superior chemical stability than corresponding acidic Ndelta-acyl derivatives of Ndelta-acyl derivatives of Nalpha(4-amino-4-deoxypteroyl)-L-ornithine compounds.
Bibliography:Application Number: EP20040713766